These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 28754782)
21. Diverse solid tumors expressing a restricted epitope of L1-CAM can be targeted by chimeric antigen receptor redirected T lymphocytes. Hong H; Stastny M; Brown C; Chang WC; Ostberg JR; Forman SJ; Jensen MC J Immunother; 2014; 37(2):93-104. PubMed ID: 24509172 [TBL] [Abstract][Full Text] [Related]
22. Immunotherapy for glioblastoma: the devil is in the details. Lesniak MS J Clin Oncol; 2011 Aug; 29(22):3105; author reply 3105-6. PubMed ID: 21709193 [No Abstract] [Full Text] [Related]
23. Glioblastoma stem-like cell lines with either maintenance or loss of high-level EGFR amplification, generated via modulation of ligand concentration. Schulte A; Günther HS; Martens T; Zapf S; Riethdorf S; Wülfing C; Stoupiec M; Westphal M; Lamszus K Clin Cancer Res; 2012 Apr; 18(7):1901-13. PubMed ID: 22316604 [TBL] [Abstract][Full Text] [Related]
24. Chimeric antigen receptors for treatment of glioblastoma: a practical review of challenges and ways to overcome them. Sengupta S; Mao G; Gokaslan ZS; Sampath P Cancer Gene Ther; 2017 Mar; 24(3):121-129. PubMed ID: 27767090 [TBL] [Abstract][Full Text] [Related]
25. Epidermal growth factor receptor-targeted immunoliposomes significantly enhance the efficacy of multiple anticancer drugs in vivo. Mamot C; Drummond DC; Noble CO; Kallab V; Guo Z; Hong K; Kirpotin DB; Park JW Cancer Res; 2005 Dec; 65(24):11631-8. PubMed ID: 16357174 [TBL] [Abstract][Full Text] [Related]
26. Affinity-Tuned ErbB2 or EGFR Chimeric Antigen Receptor T Cells Exhibit an Increased Therapeutic Index against Tumors in Mice. Liu X; Jiang S; Fang C; Yang S; Olalere D; Pequignot EC; Cogdill AP; Li N; Ramones M; Granda B; Zhou L; Loew A; Young RM; June CH; Zhao Y Cancer Res; 2015 Sep; 75(17):3596-607. PubMed ID: 26330166 [TBL] [Abstract][Full Text] [Related]
27. Therapeutic control and resistance of the EGFR-driven signaling network in glioblastoma. Azuaje F; Tiemann K; Niclou SP Cell Commun Signal; 2015 Mar; 13():23. PubMed ID: 25885672 [TBL] [Abstract][Full Text] [Related]
28. Characterization and Functional Analysis of scFv-based Chimeric Antigen Receptors to Redirect T Cells to IL13Rα2-positive Glioma. Krenciute G; Krebs S; Torres D; Wu MF; Liu H; Dotti G; Li XN; Lesniak MS; Balyasnikova IV; Gottschalk S Mol Ther; 2016 Feb; 24(2):354-363. PubMed ID: 26514825 [TBL] [Abstract][Full Text] [Related]
29. Functional design of chimeric T-cell antigen receptors for adoptive immunotherapy of cancer: architecture and outcomes. Shirasu N; Kuroki M Anticancer Res; 2012 Jun; 32(6):2377-83. PubMed ID: 22641678 [TBL] [Abstract][Full Text] [Related]
30. Recent clinical trials utilizing chimeric antigen receptor T cells therapies against solid tumors. Han S; Latchoumanin O; Wu G; Zhou G; Hebbard L; George J; Qiao L Cancer Lett; 2017 Apr; 390():188-200. PubMed ID: 28089834 [TBL] [Abstract][Full Text] [Related]
31. Rindopepimut, a 14-mer injectable peptide vaccine against EGFRvIII for the potential treatment of glioblastoma multiforme. Del Vecchio CA; Wong AJ Curr Opin Mol Ther; 2010 Dec; 12(6):741-54. PubMed ID: 21154166 [TBL] [Abstract][Full Text] [Related]
32. Herpes simplex virus 1 amplicon vector-mediated siRNA targeting epidermal growth factor receptor inhibits growth of human glioma cells in vivo. Saydam O; Glauser DL; Heid I; Turkeri G; Hilbe M; Jacobs AH; Ackermann M; Fraefel C Mol Ther; 2005 Nov; 12(5):803-12. PubMed ID: 16112910 [TBL] [Abstract][Full Text] [Related]
33. Treatment of the T98G glioblastoma cell line with antisense oligonucleotides directed toward mRNA encoding transforming growth factor-alpha and the epidermal growth factor receptor. Rubenstein M; Glick R; Lichtor T; Mirochnik Y; Chou P; Guinan P Med Oncol; 2001; 18(2):121-30. PubMed ID: 11778757 [TBL] [Abstract][Full Text] [Related]
34. EGFRvIII/integrin β3 interaction in hypoxic and vitronectinenriching microenvironment promote GBM progression and metastasis. Liu Z; Han L; Dong Y; Tan Y; Li Y; Zhao M; Xie H; Ju H; Wang H; Zhao Y; Zheng Q; Wang Q; Su J; Fang C; Fu S; Jiang T; Liu J; Li X; Kang C; Ren H Oncotarget; 2016 Jan; 7(4):4680-94. PubMed ID: 26717039 [TBL] [Abstract][Full Text] [Related]
35. EGFRvIII--a stable target for anti-EGFRvIII therapy. Banaszczyk M; Stoczynska-Fidelus E; Winiecka-Klimek M; Bienkowski M; Och W; Rieske P; Piaskowski S Anticancer Res; 2013 Dec; 33(12):5343-8. PubMed ID: 24324068 [TBL] [Abstract][Full Text] [Related]
36. Model T muscle CARs can treat brain tumors. Johnson LA Clin Cancer Res; 2012 Nov; 18(21):5834-6. PubMed ID: 23019306 [TBL] [Abstract][Full Text] [Related]
38. Nursing impact on the CAR-T cell landscape. McDermott K; Spendley L Lancet Haematol; 2020 Mar; 7(3):e192. PubMed ID: 32109403 [No Abstract] [Full Text] [Related]
39. [II. Treatment of Glioblastoma with Alternating Electric Fields]. Kamamoto D; Sasaki H Gan To Kagaku Ryoho; 2018 Jun; 45(6):927-932. PubMed ID: 30026416 [No Abstract] [Full Text] [Related]
40. CAR T cells targeting solid tumors: carcinoembryonic antigen (CEA) proves to be a safe target. Holzinger A; Abken H Cancer Immunol Immunother; 2017 Nov; 66(11):1505-1507. PubMed ID: 28755091 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]